My MS Toolkit: An Internet-Based Depression Self-Management Program fo
My MS Toolkit: An Internet-Based Depression Self-Management Program for Adults Living With Multiple Sclerosis
What it found
No result yet.
What was tested
Treatment tested
- My MS Toolkit
What it measured
Main measures
Depressive Symptom Severity
Baseline (prior to treatment), 12-week and 4-month
Mood and sleepQuality of life (reported by participants)
Other measures (12)
Sleep Disturbance
Baseline (prior to treatment), 12-week, and 4-month
Mood and sleepQuality of life (reported by participants)Fatigue Severity
Baseline (prior to treatment), 12-week, and 4-month
FatigueQuality of life (reported by participants)Fatigue Impact
Baseline (prior to treatment), 12-week, and 4-month
Thinking and memoryFatiguePain Intensity
Baseline (prior to treatment), 12-week, and 4-month
PainQuality of life (reported by participants)Anxiety
Baseline (prior to treatment), 12-week, and 4-month
Mood and sleepQuality of life (reported by participants)Pain Interference
Baseline (prior to treatment), 12-week, and 4-month
PainQuality of life (reported by participants)Social Participation
Baseline (prior to treatment), 12-week, and 4-month
PainQuality of life (reported by participants)Treatment Engagement
12-week and 4-month
Treatment Satisfaction
12-week and 4-month
Quality of life (reported by participants)Treatment Recommendation
12-week and 4-month
Mood and sleep
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Self-reported diagnosis of MS (with screening questions such as current disease modifying therapy) * At least 18 years of age * Can read, write, and speak in English * Score of >4 on the Patient Health Questionnaire, indicating at least mild depressive symptoms * Have access to an internet-connected device for accessing the intervention
Exclusion criteria
* Previous diagnosis of bipolar disorder or schizophrenia * Started medication for depression or anxiety in the past 2 months * Currently undergoing psychotherapy for depression * Are of moderate or high risk for suicide on the Columbia Suicide Severity Rating Scale (C-SSRS) * Participating in another clinical trial
As registered. Criteria can change, so ask the trial team or your neurologist.
Contact details on the registryAbout this trial
In the sponsor's words
We are conducting this study to test if the new Toolkit depression module is accessible and helpful for people with multiple sclerosis (MS) in decreasing depression severity.
Loading reviews and guidelines…
History
Started
Sept 2026
Main results due
Sept 2027
Finished
Nov 2027